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nterferon-
 
 
 
 (IFN-
 
 
 
) is believed to contribute to immune-
mediated demyelinating disorders by targeting the my-
elin-producing oligodendrocyte, a cell known to be
highly sensitive to the disruption of protein synthesis and
to the perturbation of the secretory pathway. We found
that apoptosis induced by IFN-
 
 
 
 in cultured rat oligoden-
drocytes was associated with endoplasmic reticulum (ER)
stress. ER stress also accompanied oligodendrocyte ap-
optosis and hypomyelination in transgenic mice that inap-
propriately expressed IFN-
 
 
 
 in the central nervous system
(CNS). Compared with a wild-type genetic background,
I
 
the enforced expression of IFN-
 
 
 
 in mice that were het-
erozygous for a loss of function mutation in pancreatic ER
kinase (PERK) dramatically reduced animal survival, pro-
moted CNS hypomyelination, and enhanced oligoden-
drocyte loss. PERK encodes an ER stress–inducible kinase
that phosphorylates eukaryotic translation initiation factor
2
 
 
 
 and speciﬁcally maintains client protein homeostasis
in the stressed ER. Therefore, the hypersensitivity of
 
PERK
 
 
 
/
 
 
 
 mice to IFN-
 
 
 
 implicates ER stress in demyelin-
ating disorders that are induced by CNS inﬂammation.
 
Introduction
 
The ER is a membranous labyrinthine network that extends
throughout the cytoplasm of eukaryotic cells and is contiguous
with the nuclear envelope. Approximately one third of all cel-
lular proteins, particularly membrane-spanning and secreted
proteins, are translocated into the lumen of the ER, where post-
translational modification, folding, and oligomerization occur.
The ER is also the site for the biosynthesis of steroids, choles-
terol, and other lipids, and it is the major signal-transducing or-
ganelle in the cell that continuously responds to environmental
cues to release calcium (Kaufman, 1999). A number of cell
stress conditions, such as perturbed calcium homeostasis or re-
dox status, elevated secretory protein synthesis rates, altered
glycosylation levels, and cholesterol overloading, can interfere
with oxidative protein folding. This can subsequently lead to
the accumulation of unfolded or misfolded proteins in the ER
lumen, which has been referred to ER stress (Ma and Hender-
shot, 2001; Ron, 2002; Rutkowski and Kaufman, 2004).
Three ER-resident transmembrane proteins have been
identified as proximal sensors of ER stress: pancreatic ER ki-
nase (PERK), the kinase encoded by the inositol requiring
(IRE) 1 gene, and activating transcription factor (ATF) 6. At
the onset of ER stress, the most rapidly activated pathway is
translational repression, which is mediated by PERK (Ron and
Harding, 2000). PERK couples protein folding in the ER with
protein synthesis by phosphorylating the 
 
 
 
 subunit of the eu-
karyotic translation initiation (eIF) factor 2, which attenuates
the initiation of translation in response to ER stress (Harding et
al., 1999; Okada et al., 2002). The cleavage of ATF6 and the
activation of IRE1 signaling follow fairly quickly; these pro-
cesses promote the expression of ER-localized chaperones that
facilitate the restoration of proper protein folding within the ER
(Yoshida et al., 2001; Calfon et al., 2002; Okada et al., 2002).
These protective responses act transiently to maintain homeo-
stasis within the ER, but sustained ER stress ultimately leads to
the apoptotic death of the cell (Ma and Hendershot, 2001; Ron,
2002; Rao et al., 2004; Rutkowski and Kaufman, 2004).
Oligodendrocytes produce vast amounts of myelin as an
extension of their plasma membrane; a unique, lipid-rich,
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multilamellar sheath that wraps axons in the central nervous
system (CNS). On the basis of estimates from morphometric
analysis, the mean surface area of myelin membrane per ma-
ture oligodendrocyte is 1–20 
 
 
 
 10
 
5
 
 
 
 
 
m
 
2
 
, compared with a
perikaryal surface area of only 100–300 
 
 
 
m
 
2
 
. During the active
phase of myelination, each oligodendrocyte in the CNS must
produce as much as 
 
 
 
5,000 
 
 
 
m
 
2
 
 of myelin surface area per day
and 
 
 
 
10
 
5
 
 myelin protein molecules per minute (Pfeiffer et al.,
1993). Perhaps not surprisingly, data from human hypomyeli-
nating diseases and from dysmyelinating animal models suggest
that oligodendrocytes rank among the cells that are most sensi-
tive to the disruption of protein translation and protein secretory
pathways. Leukoencephalopathy with vanishing white matter
(VWM) is caused by mutations in the gene encoding eIF-2B
(Leegwater et al., 2001; Fogli et al., 2004). Moreover, the leu-
kodystrophy Pelizaeus-Merzbacher disease (PMD), which re-
sults from mutations in the myelin proteolipid protein (PLP)
gene, is associated with perturbation of the protein secretory
pathway, as are PMD animal models with point mutations in the
PLP gene (Bauer et al., 2002; Southwood et al., 2002).
The pleotropic cytokine interferon-
 
 
 
 (IFN-
 
 
 
), which is
secreted by activated T lymphocytes and by natural killer cells,
is believed to play a deleterious role in immune-mediated de-
myelinating disorders such as multiple sclerosis (MS) and ex-
perimental allergic encephalomyelitis (Popko et al., 1997;
Popko and Baerwald, 1999; Steinman, 2001a). This cytokine,
which is normally not present in the CNS, is detectable during
the symptomatic phase of these disorders (Panitch, 1992). The
administration of IFN-
 
 
 
 to patients with MS leads to a worsen-
ing disease course (Panitch et al., 1987), and treatment of such
patients with an IFN-
 
 
 
 antibody delays disability progression
(Skurkovich et al., 2001). In vitro IFN-
 
 
 
 is capable of promot-
ing apoptosis in purified developing oligodendrocytes (An-
drews et al., 1998; Baerwald and Popko, 1998; Feldhaus et al.,
2004). Moreover, transgenic mice that ectopically express IFN-
 
 
 
in the CNS display a tremoring phenotype and myelin abnor-
malities (Corbin et al., 1996; LaFerla et al., 2000). Nevertheless,
the mechanisms by which the presence of IFN-
 
 
 
 leads to oligo-
dendroglial abnormalities and to alterations to the myelin
sheath remain poorly understood. We provide evidence for the
activation of the ER stress response in oligodendrocytes that
are exposed to IFN-
 
 
 
 in culture and in transgenic mice. More-
over, we demonstrate that PERK, a kinase that responds specif-
ically to ER stress, modulates disease severity in animals that
ectopically express IFN-
 
 
 
 and serves to protect oligodendro-
cytes from apoptosis.
 
Results
 
IFN-
 
 
 
–induced apoptosis in rat 
oligodendrocytes is associated 
with ER stress 
 
Our initial efforts to characterize the ER stress response in
oligodendrocytes exposed to IFN-
 
 
 
 were performed in vitro.
Purified oligodendrocyte progenitor cells were allowed to dif-
ferentiate for 5 d in defined media, at which point 
 
 
 
40% of
the cells expressed the myelin protein 2
 
 
 
3
 
 
 
-cyclic nucleotide
3
 
 
 
-phosphodiesterase (CNP) and extended branched processes.
These cells did not extend the flat membrane sheets that are
characteristic of more mature oligodendrocyte cultures. When
treated with 70 U/ml IFN-
 
 
 
 for 48 h, these cells showed ab-
normal morphological changes, including cell shrinkage and
aggregation of cell bodies, followed by detachment from the
Figure 1. IFN- –induced apoptosis in cultured rat oligodendrocytes is
associated with ER stress. (A) Untreated oligodendrocytes that underwent
differentiation for 7 d. (B) Oligodendrocytes that underwent differentia-
tion for 5 d and treatment with 70 U/ml IFN-  for 48 h, revealing cell
shrinkage and aggregation of cell bodies (arrow). (C and D) TUNEL and
CNP double labeling for untreated oligodendrocytes that underwent dif-
ferentiation for 7 d (C) and for oligodendrocytes that underwent differenti-
ation for 5 d and treatment with 70 U/ml IFN-  for 48 h (D). (E) Quantita-
tion of TUNEL and CNPase double positive cells; *, P   0.05. (F)
Caspase-3 activity assay in the oligodendrocyte lysates; *, P   0.01. (G)
Real-time PCR analyses of the expression of BIP, CHOP, and caspase-12
in oligodendrocytes treated with 70 U/ml IFN- ; *, P   0.05. (E–G) Error
bars represent standard deviation. (H) Western blot analyses of total eIF-
2 , p-eIF-2 , and caspase-12 in oligodendrocytes treated with 70 U/ml
IFN- . All experiments were repeated at least three times. Bars: (A and B)
30  M; (C and D) 20  M. 
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culture plate (Fig. 1, A and B). TUNEL and CNP double label-
ing revealed that IFN-
 
 
 
 induced apoptosis in a significant
number of oligodendrocytes (Fig. 1, C–E). Furthermore, the
caspase-3 activity in the cell lysates of IFN-
 
 
 
–treated oligo-
dendrocytes was markedly increased (Fig. 1 F). Thus, 70 U/ml
IFN-
 
 
 
 is able to induce apoptosis in oligodendrocytes that are
actively synthesizing myelin components.
To determine whether IFN-
 
 
 
 interferes with ER func-
tion, we monitored the expression of ER stress markers in cy-
tokine-treated oligodendrocyte cultures. The levels of mRNA
that encode the binding immunoglobulin protein (BIP)/78-kD,
glucose-regulated protein and the CAATT enhancer binding
protein homologous protein (CHOP)/growth and DNA damage
protein 153, both of which are associated with the ER stress re-
sponse, were increased 
 
 
 
2–3 times in oligodendrocytes after
exposure to IFN-
 
 
 
 (Fig. 1 G). The phosphorylation of eIF-2
 
 
 
,
which inhibits nucleotide exchange on the eIF-2 complex and
attenuates most protein synthesis, occurs within minutes after
the development of ER stress (Ron, 2002). Western blot analy-
sis revealed that IFN-
 
 
 
 significantly elevated the level of phos-
phorylated eIF-2
 
 
 
 (p-eIF-2
 
 
 
) in oligodendroglial cultures (Fig.
1 H). Caspase-12, an ER-localized caspase, is activated by ER
stress and can lead to the cleavage of caspase-3 (Nakagawa et
al., 2000; Lamkanfi et al., 2004). The induction of caspase-12
was observed after the treatment of oligodendrocytes with IFN-
 
 
 
(Fig. 1 G). Moreover, the level of the active fragment of cas-
pase-12 was strongly elevated after 48 h of IFN-
 
 
 
 treatment
(Fig. 1 H). These results indicate that IFN-
 
 
 
–induced apoptosis
in cultured oligodendrocytes is associated with the activation
of the ER stress pathway.
 
Hypomyelination induced by ectopic 
expression of IFN-
 
 
 
 is associated with 
ER stress
 
We have generated transgenic mice that allow for the temporally
regulated delivery of IFN-
 
 
 
 to the CNS using the tetracycline-
controllable system (Lin et al., 2004). To drive tetracycline-
controlled  transactivator (tTA) expression in astrocytes, we
chose the transcriptional regulatory region of the glial fibrillary
acidic protein (GFAP) gene, which has been well characterized
in transgenic studies (Brenner et al., 1994). 
 
GFAP/tTA
 
 mice
were mated with 
 
TRE/IFN-
 
 
 
 mice to produce animals that were
hemizygous for both transgenes. When these mice are main-
tained on doxycycline, the expression of the IFN-
 
 
 
 transgene is
repressed (Fig. 2 A). When double transgenic mice were re-
leased from doxycycline at embryonic day 14 (E 14), mRNA
for IFN-
 
 
 
 could be detected as early as 10 d after birth (unpub-
lished data). Real-time PCR analysis showed that these mice ex-
pressed robust levels of IFN-
 
 
 
 and major histocompatibility
complex (MHC) class I, a downstream target of IFN-
 
 
 
 activity,
in the CNS at postnatal day 14 (Fig. 2 A). The double transgenic
mice that ectopically expressed IFN-
 
 
 
 in the CNS during devel-
opment are mildly hypomyelinated (see Figs. 4 and 5). This is
consistent with observations made on previously generated
transgenic mice that expressed IFN-
 
 
 
 constitutively in oligo-
dendrocytes (Corbin et al., 1996). The diminished myelination
observed in these mice is correlated with IFN-
 
 
 
–induced oligo-
dendrocyte apoptosis (see Fig. 7, A and F). IFN-
 
 
 
 up-regulated
BIP and CHOP expression 
 
 
 
1.6 and 2 times those of the con-
trol levels and strongly enhanced caspase-12 expression in the
CNS of these animals (Fig. 2 A). More notable, the level of the
active fragment of caspase-12 was also increased in the CNS of
these animals (Fig. 2 B). Furthermore, colocalization analysis
with the CC1 antibody revealed that oligodendrocytes increased
the expression of BIP (Fig. 2, C and D), p-eIF-2
 
 
 
 (Fig. 2, E and
F), and caspase-12 (Fig. 2, G and H). These data support a link
between ER stress and IFN-
 
 
 
–induced oligodendrocyte apopto-
sis and hypomyelination during development.
 
Hypersensitivity of 
 
PERK
 
 
 
/
 
 
 
 mice to the 
conditional misexpression of IFN-
 
 
 
We next pursued a genetic approach to examine the involve-
ment of the ER stress response in the myelin perturbations that
Figure 2. Hypomyelination induced by ectopically expressed IFN-  is
associated with ER stress. (A) Real-time PCR analyses for detection of
mRNA in the brains of 14-d-old mice ectopically expressing IFN-  (n   3);
*, P   0.05; **, P   0.01. Error bars represent standard deviation. (B)
Western blot analyses for caspase-12 in the CNS of 14-d-old double
transgenic mice released from doxyclycline at E 14. (C and D) BIP and
CC1 double immunostaining in the spinal cord of 14-d-old double trans-
genic mice that received doxycycline (C) or were released from doxycy-
cline at E 14 (D). (E and F) p-eIF-2  and CC1 double immunostaining in
the spinal cord of 14-d-old double transgenic mice that received doxycy-
cline (E) or were released from doxycycline at E 14 (F). (G and H) Cas-
pase-12 and CC1 double immunostaining in the spinal cord of 14-d-old
double transgenic mice that received doxycycline (G) or were released
from doxycycline at E 14 (H). (C–H) n   3; bar, 30  M. 
JCB • VOLUME 169 • NUMBER 4 • 2005 606
 
are elicited by IFN-
 
 . Three pathways are known to signal ER
stress. The IRE1–X-box–binding protein-1 pathway is the old-
est and most conserved; however, in mammals, it appears to
have been diverted to the control of genes involved in remodel-
ing the ER to high capacity secretion (Ron and Hampton,
2004). Furthermore, both IRE1 and X-box–binding protein-1
mutant mice die at early embryonic stages, making their use to
the study of the myelination process ineffective (Ma and Hen-
dershot, 2001). Currently, there are no genetic tools available
to explore the ATF6 pathway in mice. The PERK–eIF-2  path-
way, on the other hand, contributes to the activation of most
ER stress target genes (Harding et al., 2003; Lu et al., 2004).
Moreover, although PERK /  mice have a complex pheno-
type that includes progressive diabetes mellitus, exocrine pan-
creatic insufficiency, growth retardation, and high mortality
(Harding et al., 2001; Zhang et al., 2002), PERK /  mice, al-
though healthy, display evidence of haploid insufficiency (Har-
ding et al., 2000a). Thus, to examine the influence of the ER
stress response on myelin and oligodendrocyte abnormalities
that are elicited by IFN- , we exploited PERK mutant mice
(Harding et al., 2001).
GFAP/tTA and TRE/IFN-  mice were crossed with
PERK /  mice, and the resulting progeny were intercrossed to
obtain double transgenic mice that were homozygous or het-
erozygous for the PERK mutation. As reported, the majority of
double transgenic mice with a PERK /  background died
within 12 d after birth, regardless of whether they received doxy-
cycline during the entire period or if doxycycline was switched
to water at E 14. Double transgenic GFAP/tTA; TRE/IFN- 
mice on a PERK /  background, released from doxycycline at
E 14, showed the expected minor tremor and ataxia but exhib-
ited good survival. In contrast, the double transgenic mice on a
PERK /  background had a much more severe phenotype.
These animals were considerably smaller than their IFN- –
expressing  PERK /  littermates or PERK /  animals that
did not inherit the combination of GFAP/tTA and TRE/IFN-  al-
leles and that showed severe tremor and ataxia. Approximately
two thirds of these mice experienced tonic seizures. Strikingly,
 90% of the double transgenic mice that were released from
doxycycline at E 14 on a PERK /  background died by post-
natal day 27, whereas double transgenic mice on a wild-type
background displayed normal survival (Fig. 3 A).
We next investigated the correlation between the severi-
ties of the PERK /  and PERK /  animals’ phenotype with
the animals’ capacities to attenuate protein synthesis in re-
sponse to IFN-  by examining the level of p-eIF-2 . Highly
elevated levels of p-eIF-2  in oligodendrocytes of the CNS
were observed in double transgenic mice on a PERK /  back-
ground (Fig. 2, E and F). In contrast, only a slight increase in
p-eIF-2  immunoreactivity was observed in the CNS of double
transgenic mice on a PERK /  background (Fig. 3, B and C).
Nevertheless, we did not find that the loss of function mutation
in PERK significantly affected the RNA levels of BIP, CHOP,
and caspase-12 in the CNS of mice misexpressing IFN-  (Fig.
3 D). Collectively, these data indicate that the reduced capacity
to elevate p-eIF-2  levels in response to IFN-  contributes to
the severe phenotype in mice misexpressing IFN-  on a
PERK /  background.
IFN-  misexpression leads to severe 
hypomyelination in a PERK /  background
The tremoring phenotype with tonic seizures, which was dis-
played by PERK /  mice that express IFN-  in the CNS, is
suggestive of myelin perturbations. Immunostaining for myelin
basic protein (MBP) was notably reduced in the CNS of 14-d-old
Figure 3. Hypersensitivity of PERK /  mice to the conditional misexpres-
sion of IFN- . (A) Mouse survival curve (n   40 for each group). (B and C)
p-eIF-2  and CC1 double labeling in the spinal cord of 14-d-old GFAP/tTA;
TRE/IFN- ; PERK /  mice that received doxycycline (B) or were released
from doxycycline at E 14 (C). (B and C) n   3; bar, 30  M. (D) Real-time
PCR analyses of mRNA levels in the brain of 14-d-old mice (n   3). Error
bars represent standard deviation.
Figure 4. Double transgenic mice with a PERK /  background develop
severe hypomyelination. (A and C) MBP immunostaining in the spinal
cord of 14-d-old double transgenic mice that received doxycycline (A) or
were released from doxycycline at E 14 (C). (B and D) MBP immunostaining
in the spinal cord of 14-d-old GFAP/tTA; TRE/IFN- ; PERK /  mice that
received doxycycline (B) or were released from doxycycline at E 14 (D).
(A–D) n   3; bar, 150  M.ER STRESS, INTERFERON- , AND OLIGODENDROCYTES • LIN ET AL. 607
GFAP/tTA; TRE/IFN- ; PERK /  mice released from doxy-
cycline at E 14, compared with double transgenic mice on a
wild-type background (Fig. 4). Moreover, ultrastructural exam-
ination revealed that the majority (81%   14.9%) of axons in
the spinal cord of PERK /  mice that express IFN-  in the
CNS were unmyelinated (Fig. 5). In contrast, double transgenic
animals on a wild-type background that were released from
doxycycline at E 14 displayed considerably fewer unmyelinated
axons (30%   12.9%), whereas animals that were maintained
continuously on doxycycline to repress IFN-  expression had
even fewer unmyelinated axons (9.8%   6.1%). Thus, these
data establish a correlation between the severe tremoring
phenotype induced by IFN-  on the PERK /  background
and hypomyelination.
Loss of oligodendrocytes after IFN-  
misexpression in PERK /  mice
Next, we examined the status of oligodendrocyte function in
these animals to gain insight into the cellular mechanisms that
account for the hypomyelination displayed by PERK /  mice
expressing IFN-  in the CNS. We determined the steady-state
levels of mRNAs that encode the myelin markers MBP, PLP,
and ceramide galactosyltransferase (CGT). Real-time PCR
analysis showed that MBP, PLP, and CGT mRNA levels were
slightly lower than normal in the brains of 14-d-old double
transgenic mice that were on a wild-type background and were
released from doxycycline at E 14. These mRNA levels were
even lower in the CNS of GFAP/tTA; TRE/IFN- ; PERK / 
mice released from doxycycline at E 14 (Fig. 6). To determine
whether the decreased steady-state levels of myelin protein–
encoding mRNAs were caused by reduced numbers of myeli-
nating cells, we determined oligodendroglial numbers in these
mice. Compared with control mice, there were slightly fewer
oligodendrocytes identified by CC1 immunostaining in the
CNS of 14-d-old GFAP/tTA; TRE/IFN-  transgenic mice that
were on a wild-type background and were released from doxycy-
cline at E 14 (Fig. 7 A). In contrast, very few oligodendrocytes
could be detected in the corpus callosum and in the cerebellum
of IFN- –expressing transgenic mice on a PERK /  back-
ground, and oligodendrocyte numbers in the spinal cord of
these mice were decreased by  50% (Fig. 7 A).
In addition, the number of oligodendrocytes that were
TUNEL positive in the cervical spinal cord of these mice was
2.5 times higher than the number of such cells in double
transgenic mice on a wild-type background after release from
doxycycline at E 14 (Fig. 7, B–F). Moreover, ultrastructural
examination showed that apoptotic oligodendrocytes contained
highly condensed chromatin mass, intact membrane, shrunken
cytoplasm, and apoptotic body (Fig. 7 G). These data reinforce
the hypothesis that the ER stress response is associated with
IFN- –induced oligodendrocyte apoptosis and indicate that
PERK plays a critical role in protecting oligodendrocytes from
the detrimental consequences of IFN- –induced ER stress.
Oligodendrocytes in adult animals are 
less sensitive to IFN-  than actively 
myelinating oligodendrocytes from 
younger animals
Compared with the actively myelinating oligodendrocytes of
young, growing animals, oligodendrocytes in adult mice pro-
duce lower levels of membrane proteins and lipids—just
enough to maintain homeostasis in the myelin structure (Morell
and Quarles, 1999). Thus, the ER of oligodendrocytes in adult
animals may have more spare capacity to process an increased
Figure 5. Double transgenic mice with a PERK /  background develop
severe hypomyelination. (A and B) Ultrastructural examination showing
normal myelination in the spinal cord of 14-d-old double transgenic mice
(A) and GFAP/tTA; TRE/IFN- ; PERK /  mice (B) that received doxycy-
cline. (C and D) Ultrastructural examination showing minor hypomyelination
in the spinal cord of 14-d-old double transgenic mice (C) and severe hypo-
myelination in the spinal cord of 14-d-old GFAP/tTA; TRE/IFN- ; PERK / 
mice (D) released from doxycycline at E 14. (A–D) n   3; bars, 1  M.
(E) The percentage of unmyelinated axons in the white matter of the cervical
spinal cord was calculated from three mice per time point; *, P   0.01.
Error bars represent standard deviation.
Figure 6. The levels of MBP, PLP, and CGT mRNA were significantly de-
creased in the CNS of double transgenic mice with a PERK /  background.
Real-time PCR analyses for myelin gene expression in the brain of 14-d-old
mice (n   3); *, P   0.05. Error bars represent standard deviation.JCB • VOLUME 169 • NUMBER 4 • 2005 608
protein load and, as such, may be less sensitive to disruptions of
the protein secretory pathway. To examine this possibility, dou-
ble transgenic mice were allowed to develop to maturity, at
which time IFN-  expression in the CNS was initiated. Real-
time PCR analysis showed that 4-wk-old double transgenic ani-
mals released from doxycycline started to express IFN-  at
 6 wk of age, and the levels of IFN-  mRNA and protein in the
CNS were comparable with those in developing mice released
from doxycycline at E 14 (unpublished data). IFN-  did not af-
fect oligodendrocyte survival in adult mice, even in mice on a
PERK /  background (Fig. 8, B–E). Moreover, ultrastructural
examination revealed normal myelin in the CNS of 10-wk-old
double transgenic mice with a wild-type or a PERK /  back-
ground that were released from doxycycline at 4 wk of age
(Fig. 8, F–I). A modest induction of BIP and CHOP by IFN- 
was observed in the cerebellum of 10-wk-old double transgenic
mice released from doxycycline at 4 wk of age (Fig. 8 A).
Nevertheless, colocalization analysis showed that mature oligo-
dendrocytes did not significantly increase BIP expression (Fig. 8,
B–E). Thus, our data indicate that oligodendrocytes from adult
animals are less sensitive to the presence of IFN-  than are ac-
tively myelinating oligodendrocytes of growing juvenile mice.
Discussion
The presence of the T cell–derived cytokine IFN-  within the
CNS in immune-mediated demyelinating disorders is believed
to contribute to disease pathogenesis (Steinman, 2001b; Wing-
erchuk et al., 2001). Nevertheless, the mechanism of the cyto-
Figure 7. Double transgenic mice with a PERK /  background lose the
majority of oligodendrocytes in the CNS. (A) Quantitation of CC1-positive
cells in the CNS of 14-d-old mice (n   3); *, P   0.05. (B and C) TUNEL
and CC1 double labeling in the spinal cord of 14-d-old double transgenic
mice (B) and GFAP/tTA; TRE/IFN- ; PERK /  mice (C) that received doxy-
cycline. (D and E) TUNEL and CC1 double labeling in the spinal cord of
14-d-old double transgenic mice (D) and GFAP/tTA; TRE/IFN- ; PERK / 
mice (E) released from doxycycline at E 14. (B–E) n   3; bar, 60  M; red
fluorescence shows CC1 immunoreactivity; green fluorescence shows
TUNEL stain; and blue fluorescence shows DAPI countstain. (F) Quantitation
of TUNEL and CC1 double positive cells in the spinal cord of 14-d-old
mice (n   3); *, P   0.01. (A and F) Error bars represent standard deviation.
(G) Ultrastructural examination showing that apoptotic oligodendrocytes
contained highly condensed chromatin mass, intact membrane, shrunken
cytoplasm, and apoptosis body; bar, 2  M.
Figure 8. Oligodendrocytes in adult mice are less sensitive to IFN-  than
actively myelinating oligodendrocytes from younger mice. (A) Real-time
PCR analyses of mRNA levels in the brains of 10-wk-old mice (n   3); *,
P   0.05. Error bars represent standard deviation. (B and C) BIP and CC1
double immunostaining in the cerebellum of 10-wk-old double transgenic
mice (B) and GFAP/tTA; TRE/IFN- ; PERK /  mice (C) that received doxy-
cycline. (D and E) BIP and CC1 double immunostaining in the cerebellum
of 10-wk-old double transgenic mice (D) and GFAP/tTA; TRE/IFN- ;
PERK /  mice (E) released from doxycycline at 4 wk of age. (B–E) n   3;
bar, 60  M; red fluorescence shows CC1 immunoreactivity; absence of
green fluorescence shows that no cells express detectable levels of BIP; and
blue fluorescence shows DAPI countstain. (F and G) Ultrastructural exami-
nation showing normal myelination in the cerebellum of 10-wk-old double
transgenic mice (F) and GFAP/tTA; TRE/IFN- ; PERK /  mice (G) that
received doxycycline. (H and I) Ultrastructural examination showing normal
myelination in the cerebellum of 10-wk-old double transgenic mice (H) and
GFAP/tTA; TRE/IFN- ; PERK /  mice (I) released from doxycycline at
4 wk of age. (F–I) n   3; bars, 2  M.ER STRESS, INTERFERON- , AND OLIGODENDROCYTES • LIN ET AL. 609
kine’s effect remains unresolved. In this study, we demonstrate
that the ability to respond to ER stress modulates the detrimen-
tal effects of IFN-  on the myelination process, suggesting that
this cytokine’s deleterious effects are mediated, at least in part,
by the disruption of the protein secretory pathway in oligoden-
drocytes. First, our in vitro data indicated that IFN- –induced
apoptosis in cultured rat oligodendrocytes is correlated with the
activation of the ER stress pathway in these cells. Second, we
found that hypomyelination and oligodendrocyte apoptosis in
mice that ectopically express IFN-  in the CNS during devel-
opment were also associated with ER stress. Third, animals
with a decreased capacity to respond to ER stress because of an
inactive PERK allele exhibit a dramatically increased suscepti-
bility to the presence of IFN-  in the CNS during development.
These mice exhibited a more severe behavioral phenotype and
a higher mortality, which correlated with hypomyelination and
a striking decrease in oligodendrocyte numbers in the CNS.
Evidence is accumulating that the developmental status
of oligodendrocytes influences their susceptibility to IFN- . It
has previously been demonstrated that cultured, developing oli-
godendrocytes are significantly more sensitive to the apoptotic-
inducing effects of IFN-  than are mature oligodendrocytes
(Andrews et al., 1998; Baerwald and Popko, 1998). We show
that this sensitivity correlates with the activation of the ER
stress response. Moreover, we have found that cultured imma-
ture oligodendrocytes show increased sensitivity to ER stress
induction compared with more mature oligodendrocytes, as re-
flected by a twofold increase in CHOP and BIP mRNA levels
after exposure of the cells to tunicamycin (unpublished data).
Similarly, we have previously demonstrated that the ectopic
presence of IFN-  selectively promotes hypomyelination in the
developing CNS (Corbin et al., 1996). Remarkably, the sensi-
tizing effect of the PERK mutation was also restricted to IFN- 
expression in the developing CNS. During development, ac-
tively myelinating oligodendrocytes synthesize an enormous
amount of myelin membrane, whereas oligodendrocytes in
adult animals are responsible for considerably less membrane
production, as maintenance of the myelin structure requires
only modest new protein synthesis (Morell and Quarles, 1999).
We propose that actively myelinating oligodendrocytes may be
more sensitive to the adverse effects of IFN-  because they are
synthesizing larger quantities of myelin constituents. This
physiological load of ER client proteins likely renders the de-
veloping oligodendrocytes closer to a level of physiological ER
stress threshold than oligodendrocytes from adult animals.
Our observations may have important implications for
immune-mediated demyelinating disorders such as MS, despite
the fact that these mostly afflict adults. Reparative remyelina-
tion, which follows demyelinating insults, is believed to reca-
pitulate important aspects of developmental myelination and,
therefore, might carry with it a susceptibility to ER stress.
Moreover, significantly elevated p-eIF-2  immunoreactivity
has been observed in oligodendrocytes in the course of experi-
mental allergic encephalomyelitis, an animal model of MS
(Chakrabarty et al., 2004). We propose that IFN-  produced by
T cells in MS plaques (Panitch, 1992; Vartanian et al., 1995)
promotes ER stress in actively myelinating (remyelinating) oli-
godendrocytes and may be a contributing factor to the poor re-
myelination of demyelinated axons that is observed in this
disease (Franklin, 2002; Bruck et al., 2003).
The molecular mechanism by which IFN-  activates the
ER stress response in oligodendrocytes is unclear, but it is
likely that its presence indicates an increased unfolded protein
load on the ER of these cells. It has been observed that IFN- 
stimulates the expression of hundreds of distinct proteins,
many of which are membrane spanning (particularly the anti-
gen-presenting MHC molecules of the immune system) in cul-
tured rat oligodendrocytes and in the CNS of mice ectopically
expressing IFN-  (Horwitz et al., 1999; unpublished data). Pre-
vious studies have shown that the accumulation of MHC class I
heavy chain molecules in the ER of oligodendrocytes results in
myelin abnormalities in MBP/MHC class I transgenic mice and
that the expression of IFN-  in the CNS of these mice exacer-
bates their phenotype (Baerwald et al., 2000). It is possible that
IFN-  stresses the ER of myelinating oligodendrocytes by
stimulating MHC class I expression in these cells, which, to-
gether with the load of myelin protein, leads to an overload of
the capacity of the ER, stress, and cell death.
An alternative, but not mutually exclusive, possibility is
that IFN-  stimulates ER stress in oligodendrocytes through the
activation of effector molecules. Oyadomari et al. (2001) dem-
onstrated that nitric oxide (NO) mediates the apoptotic death of
pancreatic   cells through the activation of the ER stress path-
way. Furthermore, Baud et al. (2004) recently demonstrated
that NO is toxic to developing oligodendrocytes, but that ma-
ture oligodendrocytes are less sensitive to the presence of NO.
IFN-  has been shown to increase inducible NO synthase
(iNOS) expression in certain cell types (Munoz-Fernandez and
Fresno, 1998). Nevertheless, we have not observed a significant
increase in iNOS expression in our model systems. In purified
oligodendrocyte cultures, IFN-  appears incapable of stimulat-
ing increased iNOS expression (unpublished data), which is
consistent with previous reports (Bhat et al., 1999; Molina-Hol-
gado et al., 2001). In the double transgenic animals that ex-
pressed IFN-  in the CNS, iNOS mRNA levels increased by
 50% (unpublished data). Thus, the degree to which NO plays
a role in the activation of the ER stress pathway in oligodendro-
cytes in the presence of IFN-  remains to be determined.
Oligodendrocyte function appears particularly sensitive
to disruptions of protein synthesis and to perturbations of the
secretory pathway. In addition to the evidence presented in this
study for the role of ER stress in immune-mediated demyeli-
nating disorders and for the protective function of PERK, there
are genetic myelin disorders that appear to be caused by the
disruption of these pathways. VWM is a fatal hypomyelination
disease caused by mutations in eIF-2B (Leegwater et al., 2001;
Richardson et al., 2004). The disorder affects glial cells of
white matter, with oligodendrocytes described as abnormal and
“foamy” in appearance (Wong et al., 2000). Although it is un-
clear whether mutations in eIF-2B directly contribute to the
dysfunction of oligodendrocytes, it is clear that the proper reg-
ulation of translation initiation is essential for myelination.
Moreover, PMD is caused by mutations in the PLP gene that
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secretory pathway, which appears to activate the ER stress re-
sponse in oligodendrocytes (Southwood et al., 2002). Alto-
gether, these disorders suggest that to achieve normal myelin
formation, oligodendrocytes must maintain the homeostasis of
PERK activity. Too much activity, which correlates with eIF-
2B inactivation in VWM patients, results in hypomyelination,
whereas the PERK pathway clearly provides a protective role
in disorders that result in ER stress in oligodendrocytes.
PERK has a pervasive role in the response to ER stress. In
addition to controlling protein synthesis and, thereby, the level
of client protein load on the ER (Harding et al., 1999), PERK-
mediated eIF-2  phosphorylation also activates a gene expres-
sion program with many target genes (Harding et al., 2000b,
2003). Among these is the transcription factor CHOP, whose
deletion has been noted to protect cells against death induced by
ER stress in various experimental paradigms (Zinszner et al.,
1998; McCullough et al., 2001; Oyadomari et al., 2002). Never-
theless, recent scrutiny of CHOP’s role in the death of ER-
stressed cells suggests that this phenomena reflects a failure of
homeostasis rather than the activation of a death-promoting
mechanism that is under positive selection. CHOP’s target
genes include growth and DNA damage protein 34 and ER oxi-
doreductin 1, which promote recovery from ER stress–medi-
ated translational repression and an oxidizing environment in
the ER, respectively. In certain experimental contexts, the
higher client protein load and the oxidizing environment of the
stressed CHOP /  ER is detrimental to cell survival (Marcin-
iak et al., 2004). However, it seems highly plausible that in
other contexts, such as the myelinating oligodendrocyte, the
role of these CHOP target genes in promoting the recovery of
secretory capacity may be beneficial to the organism. We have
observed reduced CHOP mRNA induction in adult PERK / 
mice that ectopically expressed IFN-  in the CNS, whereas
CHOP mRNA levels in the severely affected developing
PERK /  mice were similar to their wild-type littermates. Al-
though the CHOP data from the developing mice need to be
considered in light of the severe diminution of these very cells
(oligodendrocytes, which probably experience ER stress in
these animals), these data raise an interesting possibility that
CHOP has a protective role in oligodendrocytes. In support of
this possibility, Southwood et al. (2002) presented evidence
suggesting that CHOP serves to ameliorate the toxic effects of
mutant PLP in oligodendrocytes in a mouse model of PMD.
To summarize, we have demonstrated that the detrimental
effects of the immune-cytokine IFN-  on oligodendrocytes, in
vitro and in vivo, are associated with an activation of the ER
stress response. Moreover, we have used a genetic approach to
show that the ability of oligodendrocytes to respond to ER stress
modulates the deleterious actions of IFN-  on the myelination
process. As such, these studies have identified a potentially im-
portant clinical target in immune-mediated demyelinating disor-
ders. The presence of this cytokine in demyelinated lesions
might significantly contribute to the failed remyelination efforts
of demyelinated lesions by activating an ER stress response in
newly recruited oligodendrocytes. Therapeutic approaches to al-
leviate this stress might prove beneficial in enhancing myelin
repair in immune-mediated demyelinating disorders.
Materials and methods
Cell culture
Oligodendrocyte progenitors were cultured from neonatal rat brains (Baer-
wald and Popko, 1998). A mixed glial culture was grown in flasks in me-
dium containing 10% FBS, and when the astrocyte layer became confluent
(10–14 d), oligodendrocyte progenitors were separated from astrocytes
and microglia by using an orbital shaker. Cells ( 95% of which were
A2B5 positive, GFAP negative, and CD11b negative) were cultured in
0.5% FBS-containing medium, which also contained 10 ng/ml PDGF and
5 ng/ml FGF (both purchased from R&D Systems). Then, cells were
switched to 0.5% FBS medium without PDGF and FGF for differentiation.
After 5 d in the differentiating medium,  40% of cells were CNP positive.
70 U/ml of recombinant rat IFN-  (Calbiochem) was added to the cells
that had been allowed to differentiate for 5 d. To examine the oligoden-
droglial response to general ER stress–inducing agents, progenitor cells
that had been cultured in differentiation medium for 5 or 7 d were treated
with 2  g/ml tunicamycin (Sigma-Aldrich) for 6 h.
Mice breeding
Line110 GFAP/tTA mice and line184 TRE/IFN-  mice (Lin et al., 2004)
on the F1 hybrid background (C57BL/6; Swiss Webster) were mated with
PERK /  mice (Harding et al., 2001) on the Swiss Webster background
to obtain GFAP/tTA; PERK /  and TRE/IFN- ; PERK /  progeny on an
F2 hybrid background. Then, we mated GFAP/tTA; PERK /  mice with
TRE/IFN- ; PERK /  mice to get GFAP/tTA; TRE/IFN- ; PERK /  mice
and GFAP/tTA; TRE/IFN- ; PERK /  mice. To prevent transcriptional ac-
tivation of the TRE/IFN-  transgene by tTA, 0.05 mg/ml doxycycline was
added to the drinking water and was provided ad libitum. All animal pro-
cedures were conducted in complete compliance with the National Insti-
tutes of Health’s (NIH) Guide for the Care and Use of Laboratory Animals
and were approved by the Institutional Animal Care and Use Committee
of the University of Chicago.
Real-time PCR
RNA was isolated from cultured cells and mice brains using TRIzol reagent (In-
vitrogen) and was treated with DNaseI (Invitrogen) to eliminate genomic
DNA. Reverse transcription was performed using the SuperScript First-Strand
Synthesis System for RT-PCR kit (Invitrogen). Real-time PCR was performed
with iQ Supermix (Bio-Rad Laboratories) on a real-time PCR detection system
(model iQ; Bio-Rad Laboratories). The following primers and probes
(Integrated DNA Technologies, Inc.) for real-time PCR were used: mouse
glyceraldehyde phosphate dehydrogenase (GAPDH) sense primer (CTCAAC-
TACATGGTCTACATGTTCCA); mouse GAPDH antisense primer (CCATT-
CTCGGCCTTGACTGT); mouse GAPDH probe (TGACTCCACTCACGGC-
AAATTCAACG); mouse IFN-  sense primer (GATATCTCGAGGAACTGGCAAAA);
mouse IFN-  antisense primer (CTTCAAAGAGTCTGAGGTAGAAAGA-
GATAAT); mouse IFN-  probe (TGGTGACATGAAAATCCTGCAGAGCCA);
mouse MBP sense primer (GCTCCCTGCCCCAGAAGT); mouse MBP anti-
sense primer (TGTCACAATGTTCTTGAAGAAATGG); mouse MBP probe
(AGCACGGCCGGACCCAAGATG); mouse PLP sense primer (CACTTA-
CAACTTCGCCGTCCT); mouse PLP antisense primer (GGGAGTTTCTATGG-
GAGCTCAGA); mouse PLP probe (AACTCATGGGCCGAGGCACCAA);
mouse CGT sense primer (TTATCGGAAATTCACAAGGATCAA); mouse
CGT antisense primer (TGGCGAAGAATGTAGTCTATCCAATA); mouse CGT
probe (CCGGCCACCCTGTCAATCGG); mouse CHOP sense primer
(CCACCACACCTGAAAGCAGAA); mouse CHOP antisense primer (AGGT-
GCCCCCAATTTCATCT); mouse CHOP probe (TGAGTCCCTGCCTTTCAC-
CTTGGAGA); mouse BIP sense primer (ACTCCGGCGTGAGGTAGAAA);
mouse BIP antisense primer (AGAGCGGAACAGGTCCATGT); mouse BIP
probe (TTCTCAGAGACCCTTACTCGGGCCAAATT); mouse caspase-12
sense primer (ATGCTGACAGCTCCTCATGGA); mouse caspase-12 anti-
sense primer (TGAGAGCCAGACGTGTTCGT); mouse caspase-12 probe
(AGTCCAAGATACACTGAAGCTTTGTCCACGTGAT); rat GAPDH sense
primer (CCCCAATGTATCCGTTGTGGA); rat GAPDH antisense primer
(GCCTGCTTCACCACCTTCTT); rat GAPDH probe (ACATGCCGCCTG-
GAGAAACCTGCC); rat BIP sense primer (CCTATTCCTGCGTCGGTGTATT);
rat BIP antisense primer (GGTTGGACGTGAGTTGGTTCT); rat BIP probe
(CCGCATCGCCAATCAGACGCTCCC); rat CHOP sense primer (GAAATC-
GAGCGCCTGACCAG); rat CHOP antisense primer (GGAGGTGATGC-
CAACAGTTCA); rat CHOP probe (AGACCACACGGCGGGCTCTGATCG);
rat caspase-12 sense primer (AGAATTAATGAAGTTTGCTGGCCG); rat cas-
pase-12 antisense primer (CAGGATGCCGTGGGACATAAA); and rat cas-
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Western blot analysis
Tissues or cultured cells were rinsed in ice-cold PBS and were immedi-
ately homogenized in 5 vol Triton X-100 buffer (20 mM Hepes, pH 7.5,
150 mM NaCl, 1% Triton X-100, 10% glycerol, 1 mM EDTA, 10 mM tet-
rasodium pyrophosphate, 100 mM NaF, 17.5 mM  -glycerophosphate,
10 mM PMSF, 15  g/ml aprotonin, and 6  g/ml pepstatin A) using a
motorized homogenizer. After incubating on ice for 15 min, the extracts
were cleared by centrifugation at 14,000 rpm twice for 30 min each.
The protein content of each extract was determined by protein assay (Bio-
Rad Laboratories). The extracts (40  g) were separated by SDS-PAGE
and were transferred to nitrocellulose. The blots were incubated with
primary antibody (see below), and the signal was revealed by chemilumi-
nescence after reacting with HRP-conjugated second antibody. The fol-
lowing primary antibodies were used: anti–eIF-2  (1:500; Santa Cruz
Biotechnology, Inc.); anti–p-eIF-2  (1:1,000; Cell Signaling Technology);
anti–caspase-12 (1:500; Santa Cruz Biotechnology, Inc.); and antiactin
(1:1,000; Sigma-Aldrich).
Caspase-3 activity assay
Activation of caspase-3 was assessed by using the fluorimetric Caspase-3
Assay Kit (Sigma-Aldrich) according to the manufacturer’s instructions.
Immunohistochemistry
Anesthetized mice were perfused through the left cardiac ventricle with
4% PFA in PBS. The half saggital brains and transverse cervical spinal
cords were removed, postfixed with PFA, cryopreserved in 30% sucrose,
embedded in optimal cutting temperature compound, and frozen on dry
ice. Frozen sections were cut in a cryostat at a thickness of 10  m. For im-
munohistochemistry, frozen sections were treated with  20 C acetone,
blocked with PBS containing 10% NGS and 0.1% Triton X-100, and incu-
bated overnight with the primary antibody diluted in blocking solution. Flu-
orescein, Texas red, or enzyme-labeled secondary antibodies (Vector Lab-
oratories) were used for detection. Immunohistochemistry for CC1 (APC7,
1:50; EMD Biosciences, Inc.), BIP (1:50; Santa Cruz Biotechnology, Inc.),
caspase-12 (1:50; Santa Cruz Biotechnology, Inc.), p-eIF-2  (1:50; Cell
Signaling Technology), and MBP (1:1,000; Sternberger Monoclonals)
was performed. The fluorescent-stained sections were mounted with
Vectashield mounting medium with DAPI (Vector Laboratories) and were
visualized with a fluorescence microscope (model Axioplan; Carl Zeiss
MicroImaging, Inc.) using a 40  objective (1.3 oil, model Achrostigmat;
Carl Zeiss MicroImaging, Inc.) or a 63  objective (1.4 oil, model Plan-
Apochromat; Carl Zeiss MicroImaging, Inc.). Images were captured using
a camera (model PXL CCD; Photometrics) connected to a computer (Ap-
ple) with the Open Lab software suite. We quantified immunopositive cells
by counting positive cells within the white matter of the spinal cord, cere-
bellum, and corpus callosum. Only those cells with nuclei that were ob-
servable by DAPI staining were counted.
TUNEL assay
CNP (1:200; Sternberger Monoclonals) and TUNEL double staining in cul-
tured cells and CC1 and TUNEL double staining in mice tissue were per-
formed using the ApopTag Kit (Serologicals Corp.) following the manufac-
turer’s instructions.
Electron microscopy
Mice were anesthetized and perfused with 4% PFA and 2.5% glutararal-
dehyde. The cervical spinal cord and white matter of the cerebellum and
corpus callosum were processed. Thin sections were cut, stained with ura-
nyl acetate and lead citrate, and analyzed as previously described (Coet-
zee et al., 1996).
Statistics
Data are expressed as mean   SEM. Multiple comparisons were statisti-
cally evaluated by a one-way analysis of variance between groups test us-
ing Sigmastat 3.1 software (Hearne Scientific Software). Differences were
considered statistically significant if P   0.05.
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